Determinants of non-adherence to adjuvant endocrine treatment in early stage breast cancer patients: A Swedish population-based registry linkage study.

被引：0
|
作者：
Wulaningsih, Wahyu
Garmo, Hans
Ahlgren, Johan
Van Hemelrijck, Mieke
Lambe, Mats
机构：
[1] Gadjah Mada Univ, Yogyakarta, Indonesia
[2] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London, England
[3] Orebro Univ Hosp, Dept Oncol, Orebro, Sweden
[4] Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England
[5] Univ Uppsala Hosp, Reg Canc Ctr, Uppsala, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
535
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study
    Hsieh, Kun-Pin
    Chen, Li-Chia
    Cheung, Kwok-Leung
    Chang, Chao-Sung
    Yang, Yi-Hsin
    PLOS ONE, 2014, 9 (02):
  • [32] Impact of adjuvant treatment in elderly patients with locally advanced rectal cancer: A population-based retrospective study.
    Liu, Shiru Lucy
    O'Brien, Pierre
    Zhao, Yizhou
    Hopman, Wilma M.
    Lamond, Nathan William Dana
    Ramjeesingh, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer
    Nancy K. Janz
    Mahasin Mujahid
    Paula M. Lantz
    Angela Fagerlin
    Barbara Salem
    Monica Morrow
    Dennis Deapen
    Steven J. Katz
    Quality of Life Research, 2005, 14 : 1467 - 1479
  • [34] Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer
    Janz, NK
    Mujahid, M
    Lantz, PM
    Fagerlin, A
    Salem, B
    Morrow, M
    Deapen, D
    Katz, SJ
    QUALITY OF LIFE RESEARCH, 2005, 14 (06) : 1467 - 1479
  • [35] Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients
    Yusufov, Miryam
    Nathan, Margo
    Wiley, Aleta
    Russell, Julia
    Partridge, Ann
    Joffe, Hadine
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 53 - 62
  • [36] Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients
    Miryam Yusufov
    Margo Nathan
    Aleta Wiley
    Julia Russell
    Ann Partridge
    Hadine Joffe
    Breast Cancer Research and Treatment, 2021, 185 : 53 - 62
  • [37] RE: Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early stage breast cancer patients
    Xiao‑Min Li
    Hong-Lin Chen
    Breast Cancer Research and Treatment, 2021, 186 : 585 - 586
  • [38] RE: Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early stage breast cancer patients
    Li, Xiao-Min
    Chen, Hong-Lin
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (02) : 585 - 586
  • [39] Axillary management in early breast cancer: Surgeon attitudes in a population-based study.
    Morrow, Monica
    Katz, Steven J.
    Jagsi, Reshma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Treatment variation in patients diagnosed with early stage breast cancer in Alberta from 2002 to 2010: a population-based study
    Fisher, Stacey
    Gao, He
    Yasui, Yutaka
    Dabbs, Kelly
    Winget, Marcy
    BMC HEALTH SERVICES RESEARCH, 2015, 15
12345